dog
extens
use
anim
model
medic
research
drug
evalu
studi
human
breast
cancer
carcinogenesi
abdelmege
moham
duchenn
muscular
dystrophi
dmd
well
manag
furcat
defect
afifi
et
al
chronic
myocardi
infarct
mi
xiong
et
al
compar
pathogenesi
studi
canin
influenza
viru
civ
challeng
luo
et
al
long
term
safeti
efficaci
aav
gene
therapi
lee
et
al
therefor
critic
make
sure
dog
use
laboratori
anim
free
special
pathogen
china
accord
nation
standard
laboratori
dog
rabi
viru
rv
canin
parvoviru
cpv
canin
adenoviru
cav
canin
distemp
viru
cdv
item
must
test
laboratori
dog
live
hous
check
virus
regularli
qualiti
monitor
howev
current
exist
detect
method
recommend
industri
standard
convent
pcr
complet
whole
check
routin
four
individu
pcr
carri
timeconsum
especi
deal
larg
scale
sampl
rapid
sensit
multiplex
pathogen
detect
technolog
need
meet
detect
requir
monitor
anim
health
statu
sanitari
live
environ
unlik
exist
multiplex
pcr
method
focu
two
three
target
adapt
highthroughput
test
luminesc
bead
novel
platform
multiplex
highthroughput
detect
simultan
detect
target
singl
reaction
dunbar
liu
et
al
tool
adapt
use
genet
analysi
gene
express
analysi
snp
analysi
pathogen
identif
chen
et
al
ocheretina
et
al
zhang
et
al
luminex
xtag
assay
design
multipl
nucleic
acid
detect
singl
reaction
hybrid
magnet
microspher
pcr
product
chen
et
al
reslova
et
al
magnet
microspher
precoupl
antimagplextag
oligonucleotid
captur
match
oligonucleotid
present
end
pcr
amplicon
luminex
fluoresc
reader
use
analyt
measur
bead
type
technolog
commerci
avail
respiratori
viral
pathogen
gastrointestin
pathogen
human
clinic
diagnos
pabbaraju
et
al
duong
et
al
bare
report
applic
veterinari
research
fulfil
test
need
laboratori
dog
supplier
four
virus
canin
parainfluenza
viru
cpiv
figur
specif
analysi
luminex
xtag
assay
bar
repres
averag
mfi
duplic
sampl
cdv
canin
distemp
viru
cpv
canin
parvoviru
cav
canin
adenoviru
cpiv
canin
parainfluenza
viru
rv
rabi
viru
prv
pseudorabi
viru
ccv
canin
coronaviru
civ
canin
influenza
viru
nc
neg
control
water
result
luminex
xtag
assay
show
high
specif
figur
sensit
analysi
xtag
assay
clone
gene
copi
indic
virus
transcrib
vitro
use
triplic
detect
limit
five
virus
multiplex
assay
rapid
detect
cdv
cpv
rv
cav
cpiv
singl
tube
base
luminex
xtag
technolog
develop
valid
canin
distemp
viru
cpv
obtain
institut
anim
health
guangdong
academi
agricultur
scienc
guangzhou
china
nucleic
acid
genom
canin
coronaviru
ccv
pseudorabi
viru
prv
civ
subtyp
nobivac
dhppi
vaccin
cdv
cpv
cpiv
intervet
boxmeer
netherland
preserv
laboratori
rabi
vaccin
polyval
vaccin
cdv
cpv
rv
cpiv
wuxin
pharmaceut
changchun
china
obtain
veterinari
epidem
prevent
station
dongguan
china
virus
nucleic
acid
vaccin
store
c
use
clinic
sampl
obtain
local
veterinari
clinic
guangzhou
china
dna
rna
extract
use
commerci
automat
nucleic
acid
extract
instrument
tiangen
biotech
beij
china
accord
manufactur
instruct
viral
genom
ncbi
databas
align
determin
conserv
genom
region
viru
primer
design
use
primer
premier
softwar
inspect
vector
nti
softwar
tabl
forward
primer
modifi
specif
oligonucleotid
tag
enabl
magnet
microspher
conjug
end
revers
primer
biotinyl
enabl
detect
use
streptavidinrphycoerythrin
sape
primer
oligonucleotid
analyz
tagit
oligo
design
softwar
purifi
highperform
liquid
chromatographi
invitrogen
guangzhou
china
multiplex
amplif
perform
use
onestep
rtpcr
assay
kit
qiagen
hilden
germani
total
volum
suggest
manufactur
amplif
step
c
min
c
min
cycl
c
c
c
final
step
min
c
sampl
test
triplic
assay
run
posit
neg
control
magplextag
microspher
purchas
luminex
austin
tx
unit
state
suspend
tetramethylammonium
chlorid
outlin
manufactur
protocol
nucleic
acid
hybrid
carri
volum
includ
amplifi
product
work
microspher
mixtur
contain
bead
targetspecif
microspher
sape
hybrid
carri
c
min
product
analyz
use
luminex
reader
luminex
immedi
hybrid
result
express
mean
fluoresc
intens
mfi
pseudorabi
viru
civ
ccv
sampl
use
templat
amplif
reaction
determin
assay
specif
amplifi
product
sequenc
verif
sangon
biotech
guangzhou
china
sensit
test
carri
use
pcr
product
cdv
cpv
cav
rv
cpiv
amplif
clone
pgem
easi
vector
promega
madison
wi
unit
state
cdv
rv
cpiv
vitro
transcrib
use
rna
polymeras
ribomax
larg
scale
rna
product
kit
promega
accord
manufactur
instruct
rnasefre
dnase
promega
use
remov
plasmid
dna
transcript
trizol
ls
reagent
invitrogen
carlsbad
ca
unit
state
use
rna
isol
accord
manufactur
instruct
genom
copi
number
calcul
base
nucleic
acid
concentr
molecular
weight
tenfold
serial
dilut
dna
rna
standard
use
assay
templat
sampl
test
triplic
consid
sampl
spf
dog
live
hous
test
neg
clinic
sampl
anim
hospit
need
evalu
xtag
assay
clinic
sampl
includ
fece
saliva
throat
swab
urin
dog
test
use
convent
pcr
tabl
luminex
xtag
assay
besid
artifici
mix
infect
sampl
mix
posit
nucleic
acid
togeth
mix
posit
sampl
togeth
nucleic
acid
extract
test
valid
xtag
assay
sampl
test
duplic
addit
compar
test
carri
use
cdvcpv
test
card
quick
biotech
shanghai
china
follow
manufactur
instruct
mean
fluoresc
intens
valu
calcul
use
softwar
suppli
luminex
reader
count
least
bead
bead
set
sampl
ponzoni
et
al
background
calcul
use
blank
control
contain
hybrid
compon
except
target
dna
rna
cutoff
valu
bead
set
defin
net
mfi
valu
neg
control
sd
previous
defin
dangoudoubiyam
et
al
nucleic
acid
prv
civ
ccv
use
templat
studi
evalu
specif
multiplexpcr
primer
result
show
primer
pair
found
detect
specif
viral
target
amplif
nontarget
sampl
fluoresc
signal
observ
posit
control
figur
reveal
good
specif
assay
sensit
test
use
serial
dilut
standard
limit
detect
defin
highest
dilut
result
mfi
valu
cutoff
valu
studi
five
virus
share
differ
cutoff
valu
base
mfi
valu
neg
control
data
analysi
show
limit
detect
five
virus
figur
tabl
reproduc
stabil
assay
determin
use
parallel
reaction
concentr
standard
dnarna
interassay
varianc
less
intraassay
varianc
less
low
interassay
intraassay
coeffici
variat
demonstr
high
repeat
xtag
assay
tabl
total
number
clinic
sampl
evalu
luminex
xtag
assay
convent
pcr
posit
rate
cdv
cpv
cav
cpiv
respect
sampl
test
posit
rv
mix
infect
identifi
detect
result
two
method
agreement
posit
detect
rate
cdv
test
card
fulli
consist
xtag
assay
howev
sampl
test
posit
cpv
test
card
three
posit
sampl
confirm
sequenc
fals
detect
neg
certain
extent
xtag
assay
sensit
colloid
gold
test
strip
reveal
comparison
result
supplementari
tabl
determin
util
multiplex
xtag
assay
multiplex
infect
artifici
mix
infect
sampl
test
three
sampl
found
tripl
infect
four
sampl
found
doubl
infect
figur
indic
new
develop
multiplex
xtag
assay
abil
identifi
differ
target
coinfect
sampl
multiplex
pcr
format
allow
simultan
detect
differ
nucleic
acid
sequenc
singl
reaction
timeand
laborsav
interpret
convent
multiplex
pcr
reli
amplicon
size
restrict
use
highthroughput
format
piewbang
et
al
luminex
xtag
platform
use
studi
develop
specif
sensit
highthroughput
assay
expand
includ
pathogen
need
jiang
et
al
format
wide
use
human
diseas
diagnosi
avail
dog
wessel
et
al
dunbar
et
al
laamiri
et
al
dog
import
experiment
anim
strict
qualiti
control
cdv
cpv
cav
rv
pathogen
must
exclud
accord
nation
standard
laboratori
anim
china
xtag
technolog
use
develop
high
throughput
assay
rapid
sensit
simultan
detect
virus
help
laboratori
dog
daili
monitor
studi
luminex
xtag
assay
simultan
detect
cdv
cpv
cpiv
cav
rv
singl
reaction
develop
valid
first
report
luminex
xtag
assay
use
canin
pathogen
identif
expect
replac
current
exist
singl
pcr
method
canin
daili
monitor
howev
panel
may
good
tool
clinic
diagnosi
compar
fast
easi
pointofcar
test
poct
primer
design
key
establish
luminex
xtag
assay
unwant
hairpin
structur
would
increas
mfi
background
bioinformat
analysi
appli
evalu
specif
avoid
primer
dimer
specif
primer
target
conserv
genom
region
viru
select
approach
yield
assay
without
crossreact
target
nontarget
virus
limit
detect
multiplex
luminex
xtag
assay
estim
use
viral
dnarna
gener
clone
viral
fragment
assay
sensit
might
slightli
lower
realtim
pcr
schlottau
et
al
valid
clinic
sampl
reveal
coincid
rate
convent
pcr
detect
indic
assay
suffici
detect
five
pathogen
clinic
sampl
artifici
mix
infect
sampl
verifi
reveal
assay
capabl
identifi
specif
target
coinfect
sampl
studi
novel
multiplex
platform
simultan
detect
five
import
canin
viral
pathogen
establish
assay
use
anim
health
statu
live
hous
monitor
addit
target
integr
exist
multiplex
platform
need
allow
increas
flexibl
diseas
investig
environment
monitor
mw
carri
data
analysi
manuscript
write
fc
yz
yl
particip
manuscript
prepar
mc
rh
pg
design
experi
author
read
approv
final
manuscript
studi
also
support
nation
key
technolog
r
program
extern
fund
bodi
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
supplementari
materi
articl
found
onlin
http
supplementarymateri
